一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Biomolecules >>article
Biomolecules

Biomolecules

IF: 4.8
Download PDF

Dual PARP and RAD51 Inhibitory Drug Conjugates Show Synergistic and Selective Effects on Breast Cancer Cells

Published:3 July 2021 DOI: 10.3390/biom11070981 PMID: 34356606
Matthews M Malka, Julia Eberle, Kathrin Niedermayer, Darius P Zlotos, Lisa Wiesmüller

Abstract

The genetic principle of synthetic lethality has most successfully been exploited in therapies engaging Poly-ADP-ribose-polymerase (PARP) inhibitors to treat patients with homologous recombination (HR)-defective tumors. In this work, we went a step further following the idea of a local molecular cooperation and designed hybrid compounds M1-M3. The drug conjugates M1-M3 combine Olaparib, the first PARP inhibitor approved for clinical use, with Cpd 1, an inhibitor of RAD51 that blocks its HR functions and yet permits RAD51 nucleoprotein filament formation on single-stranded DNA. While in M2 and M3, the parental drugs are linked by -CO-(CH2)n-CO-spacers (n = 2 and 4, respectively), they are directly merged omitting the piperazine ring of Olaparib in M1. Monitoring anti-survival effects of M1-M3 in six breast cancer cell lines of different molecular subtypes showed that in each cell line, at least one of the drug conjugates decreased viability by one to two orders of magnitude compared with parental drugs. While triple-negative breast cancer (TNBC) cells with frequent BRCA1 pathway dysfunction were sensitive to spacer-linked hybrid compounds M1 and M2 regardless of their HR capacities, non-TNBC cells were responsive to the merged drug conjugate M1 only, suggesting different spatial requirements for dual inhibition in these two groups of cell lines. These results demonstrate that, depending on chemical linkage, dual PARP1-RAD51 inhibitory drugs can either sensitize non-TNBC and re-sensitize TNBC cells, or discriminate between these groups of cells.

Substances (6)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Olaparib 763113-22-0 C24H23FN4O3 687 suppliers $11.00-$2147.10
Olaparib 763113-22-0 C24H23FN4O3 687 suppliers $11.00-$2147.10
Olaparib 763113-22-0 C24H23FN4O3 687 suppliers $11.00-$2147.10
Olaparib 763113-22-0 C24H23FN4O3 687 suppliers $11.00-$2147.10
AZD2281 763113-22-0 C24H23FN4O3 - Inquiry
AZD2281 763113-22-0 C24H23FN4O3 - Inquiry

Similar articles

IF:4.4

Inhibitory effects of circR-127aa on gastric cancer progression and tumor growth

Cellular signalling Lei Qiao, Wen Pan,etc Published: 22 November 2024
IF:6.9

Therapeutic effects of guanidine hydrochloride on breast cancer through targeting KCNG1 gene.

Biomedicine & Pharmacotherapy Mehdi Roshanian Bakhsh, Leila Rouhi,etc Published: 1 August 2023
兴隆县| 上栗县| 乌鲁木齐县| 普定县| 苍溪县| 巴彦淖尔市| 江孜县| 吴旗县| 韩城市| 广水市| 高要市| 莆田市| 白河县| 南皮县| 华池县| 镇平县| 富顺县| 高州市| 铜山县| 沾益县| 乌拉特前旗| 济阳县| 绥芬河市| 棋牌| 来宾市| 长宁区| 都昌县| 阳江市| 乌什县| 攀枝花市| 上饶县| 白银市| 阳原县| 黄陵县| 盱眙县| 天长市| 合肥市| 仙居县| 和顺县| 商丘市| 南江县|